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Neuronal migration leads to a highly organized
laminar structure in the mammalian brain, and its
misregulation causes lissencephaly and behavioral
and cognitive defects. Reelin signaling, which is
mediated in part by a key adaptor, disabled-1
(Dab1), plays a critical but incompletely understood
role in this process. We found that the neuron-
specific RNA-binding protein Nova2 regulates neu-
ronal migration in late-generated cortical and Pur-
kinje neurons. An unbiased HITS-CLIP and exon
junction array search for Nova-dependent reelin-
pathway RNAs at E14.5 revealed only one candi-
date—an alternatively spliced isoform of Dab1
(Dab1.7bc). In utero electroporation demonstrated
that Dab1.7bc was sufficient to induce neuronal
migration defects in wild-type mice and exacerbate
defects when Dab1 levels were reduced, whereas
Dab1 overexpression mitigates defects in Nova2
null mice. Thus, Nova2 regulates an RNA switch
controlling the ability of Dab1 to mediate neuronal
responsiveness to reelin signaling and neuronal
migration, suggesting new links between splicing
regulation, brain disease, and development.
INTRODUCTION
The laminar structure of the mammalian brain is generated by
waves of neuronal migration that are coordinated in time and
space. Human and mouse genetic studies have revealed critical
genes, such as Reelin-Dab1 pathway, doublecortin (DCX), LIS1,
and NUDEL, that are implicated in this process (Ayala et al.,
2007). Proper lamination of the mammalian neocortex is depen-
dent on an inside-out gradient of reelin protein secreted from
Cajal-Retzius cells. This process is unique to mammals, because
lower vertebrates do not use radial ‘‘inside-out migration’’
(Molnar et al., 2006; Rakic, 2003), although they do make reelin
proteins. Therefore, evolutionary modifications and amplifica-
tions of reelin-Dab1 signaling are thought to play a key role in
evolution of the mammalian cortex, although their precise nature
remains uncertain. These distinctions are of clinical as well as
fundamental interest, because defects of these signaling path-848 Neuron 66, 848–858, June 24, 2010 ª2010 Elsevier Inc.ways are implicated in many brain disorders, including lissence-
phaly, epilepsy, and schizophrenia (Ayala et al., 2007; Gleeson
and Walsh, 2000; Rakic, 2003).
Brain development, including regional identity, mitotic activity,
cell fate determination, and differentiation, has been related to
regional specification by transcriptional factors, extrinsic factors,
and cell-cell interactions. However, the sequencing of complete
genomes and the realization that both humans and worms
harbor on the order of 20,000 protein-coding genes, whereas
human and chimpanzee genomes are 99.7% identical, has led
to the belief that species diversity may depend on the posttran-
scriptional complexity of RNA processing (Licatalosi and Darnell,
2010; Ponting et al., 2009). Indeed, the fastest evolving differ-
ence identified to date between humans and chimpanzees is in
a gene encoding a noncoding RNA (HAR1F) that is expressed
during the critical period for neuronal migration where it colocal-
izes with reelin in Cajal-Retzius cells (Amadio and Walsh, 2006;
Pollard et al., 2006). It may be anticipated that RNA regulation
will play roles in establishing brain complexity during develop-
ment, although how such regulation may be manifest is currently
unclear.
Genetic studies have indicated that RNA misregulation is
involved in a growing list of neurodevelopmental disorders,
including fragile X syndrome, spinal muscular atrophy, spinocer-
ebellar ataxias, and others (Cooper et al., 2009; Licatalosi and
Darnell, 2006; Lukong et al., 2008). Relatively little is known
about specific roles that RNA regulation plays in the developing
mammalian brain in vivo. Two different forms of ROBO3, which
arise by alternative splicing, act tightly in commissural axon
midline crossing (Chen et al., 2008) although the factors that
regulate ROBO3 splicing are unknown. In neuronal cell lines,
a switch between expression of two paralogous RNA-binding
proteins (RBPs), Ptbp1 and Ptbp2 (Boutz et al., 2007; Makeyev
et al., 2007), as well as expression of the Musashi and Elavl family
of RBPs (Sakakibara et al., 2002; Okano et al., 2005; Akamatsu
et al., 1999), regulate RNA transcripts during mammalian neu-
ronal differentiation.
Alternative splicing provides a major means of generating
protein diversity from single genes, providing a significant source
of variation in cell type, tissue type, and species variation
(Li et al., 2007; Wang et al., 2008). Alternative splicing is regu-
lated through the action of numerous RBPs. Recent advances
have dramatically increased our understanding of this regulation,
through the development of genomewide analyses such as
microarray, including exon-junction array and tiling array, RNA
Seq, and HITS-CLIP to assess protein-RNA interactions in vivo
Figure 1. Loss of Nova2 Results in Mislocation of Late-Generated
Cortical Neurons, and, to a Lesser Degree, Disorganization of
Early-Generated Cortical Neurons
(A) Sagittal sections of P10 WT and Nova2 KO (N2KO) neocortex at the level of
the anterior hippocampus were immunostained with layer-specific marker
proteins, Brn-2 (Layer II–III, V in part; green), Er81 (Layer V; red), and DAPI
(blue).
(B) FoxP2 (Layer V–VI; green) or Cux1 (Layer II–IV; red). High magnification of
deep layers in Nova2 KO is shown (box region in B). These two marker proteins
are not completely merged. Scale bar, 100 mm.
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Darnell, 2010). These techniques have begun to lead to the
discovery of new features of RNA regulation, suggesting, for
example, that the position of protein-RNA interaction determines
the outcome of alternative splicing (Chen and Manley, 2009),
or that regulatory factors such as Nova control of transcripts
encoding biologically coherent sets of proteins (Huang et al.,
2005; Ruggiu et al., 2009; Ule et al., 2005b).
Here, we find that Nova2 deficiency results in aberrant migra-
tion of cortical and Purkinje neurons, but not alterations of neural
progenitor cell fate, suggesting that alternative splicing mediated
by Nova2 regulates migration of postmitotic neurons and plays
an important role in lamination of the brain. Exon junction arrays
(Ule et al., 2005a) and HITS-CLIP were used previously to
generate genomewide maps of functional RBP-RNA interactions
(Darnell, 2010) including Nova-RNA maps (Licatalosi et al, 2008;
Ule et al., 2006), and here we used these strategies in a more
directed manner to refine the search for biologically relevant
Nova2 RNA targets in the Reelin signaling pathway. These
studies revealed that only one RNA among 20 candidates
assessed, encoding Dab1, an adaptor molecule mediating
signaling from reelin receptors, is the responsible transcript
mediating Nova2-dependent neuronal migration. These data
illustrate the use of high-throughput RNA methods to reveal a
previously unsuspected alternative splicing switch that controls
neuronal migration, demonstrating that Nova2 regulation of alter-
native splicing plays a critical role in brain development by regu-
lating reelin-Dab1 signaling in a neuron-cell autonomous manner.
RESULTS
Laminar Structure Defect of Neocortex
in Nova2 Null Mice
Nova was identified as a target antigen in a human neurological
syndrome characterized by ataxia and tremor (Darnell, 2006),
a phenotype also reported in mice harboring defects in neuronal
migration (Rice and Curran, 2001). Although biochemical and
genetic studies revealed that Nova proteins regulate transcripts
encoding synapse related molecules in the postnatal brain
(Darnell, 2006; Licatalosi et al., 2008; Ule et al., 2005b), develop-
mental actions of Nova proteins have not previously been
explored. We found that at mouse embryonic day 14.5 (E14.5)
and postnatal day 0 (P0), Nova2 protein is expressed in all
cortical layers, including postmitotic migrating neurons and the
cortical plate, whereas Nova1 is not detectable (Yang et al.,
1998) (see Figures S1A and S1B available with this article online).
We compared the laminar structure of the neocortex in wild-type
(WT) and Nova2 null (Nova2 KO; see Huang et al., 2005) mice at
P10 by histological analysis with markers for transcription
factors expressed in different cortical layers (Molyneaux et al.,
2007). Double staining with Brn-2 (Layer II/III and Vb) and Er81
(Layer V) revealed a reduced upper cortical layer and a concom-
itant increase in mislocalized Brn-2-positive cells/Er81-negative
cells under layer V neuron in Nova2 KO (Figures 1A, S1C, and
S1F). These ectopic cells expressed the neuronal marker NeuN
(Figure S1C). Similarly, Cux1-positive (Layer II–IV) /Brn-2-nega-
tive cells were also mislocated in the deep cortical layer
(Figure S1E). We noted two visible bands of neurons positivefor Cux1—one localized in the correct position in the upper layer
and a second mislocalized in the periventricular area under
FoxP2-positive (Layer V–VI) neurons (Figure 1B). The FoxP2
and ectopic Cux1-positive neurons were distinct (Figure 1B),
suggesting that the cell fate for the ectopic Layer II–IV and Layer
V neurons remained distinct. This mutant phenotype was very
similar to that seen in mice in which the reelin receptor ApoER2
is disrupted (Hack et al., 2007), and suggested that some late-
born neurons in Nova2 KO do not migrate normally to the
brain surface.
Nova2 Regulates Neuronal Migration
in Late-Generated Neurons
To clarify when the aberrantly positioned neurons in Nova2 KO
were born, we performed BrdU-labeling experiments to labelNeuron 66, 848–858, June 24, 2010 ª2010 Elsevier Inc. 849
Figure 2. Nova2 Controls Laminar Forma-
tion of Late-Generated Neurons
(A and C) BrdU labeling was performed at E14.0 or
E16.0, and cortical sections of WT or Nova2 KO
animals were immunostained with BrdU antibody
at P0, as indicated. (B and D) Graphs show a quan-
tification of BrdU-positive cells percentage in each
of 10 bins (along the dorsal/ventral axis) relative to
the total number of BrdU-positive cells in WT or
Nova2 KO. Data represent mean ± standard devi-
ation (SD) from experiments using three indepen-
dent animals for each genotype. Results showed
statistically significant differences for Nova2 KO
relative to WT in both E14 and E16 BrdU injections
(F(9,35) = 6.56; p < 0.0001; F(9.35) = 2.9348;
p = 0.0106, respectively, by repeated-measures
ANOVA). Scale bar, 100 mm.
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neurons are born, and analyzed their location at P0. In WT
cortex, a single peak of labeled cells was evident in the outer
cortex (Figure 2A, fraction 3 and Figure S2A), with cells in
a more superficial cortical layer after E16 relative to E14 BrdU
injection, as expected given the inside-out nature of laminar
cortical generation (Cooper, 2008; Rakic, 2003). In contrast,
BrdU labeling of cells in Nova2 KO cortex at either E14 or E16
led to formation of a reduced number of outer cortical neurons
and a new ectopic BrdU-positive band of cells in deep cortical
layers (Figures 2A and 2B, fraction 6 and Figure S2A). We
confirmed that these mismigrated BrdU-positive cells were
Cux1-positive neurons in P10 Nova2 KO deep layers (Fig-
ure S2B). We also found a small number of mislocalized Er81-
positive neurons in P10 Nova2 KO (Figure S1D, arrow). These
cells, committed to a deep layer, are known to be born at early
stages of cortical development, around E12–13 (Takahashi
et al., 1999). BrdU labeling of cells in Nova2 KO at E12 exhibited
no ectopic BrdU-positive band and very few mislocalized cells
when analyzed at P0 (Figure S2C, arrow). These results sug-
gest that Nova2 regulates neuronal migration during cortical
development and that its action is mainly late-born neurons
rather than early-born neurons.
Next, to assess the proliferation and localization of neural
stem/progenitor cells in Nova2 KO cortex, we performed BrdU
short-term labeling and immunostaining with a marker for M
phase (phospho-Histone 3; PH3). WT and Nova2 KO embryos
fixed 1 hr after BrdU injections at E14.5 showed no difference850 Neuron 66, 848–858, June 24, 2010 ª2010 Elsevier Inc.in BrdU-positive cell number or the loca-
tion of PH3-positive cells, which were
located at the ventricular surface with
minor populations in subventricular zone
in both genetic backgrounds (Figures
3A–3C and S3). Taken together, these
BrdU-labeling experiments indicated that
the observed neuronal migration defect in
Nova2 KO mice could be due to a failure
of postmitotic neurons to reach brain
surface, but not to a defect in proliferation
of progenitor cells or morphology ofradial glia (Figure 3A). Therefore, these data suggest that the
migration defect is intrinsic to newborn cortical neurons after
their final cell division.Nova2 Regulates Radial Migration of Purkinje Neurons
Some cases of mutant mice showing cortical migration defects
also have ectopic Purkinje neurons in the cerebellum as a result
of radial migration defects of Purkinje neurons (Howell et al.,
1997b; Larouche et al., 2008; Sheldon et al., 1997). Therefore,
we performed histological analysis of the developing cerebellum
in Nova2 KO mice. In the E18.5 cerebellum, calbindin-positive
young migrating Purkinje neurons express Nova2, but not
Nova1 (which is expressed in the deep nuclei), as evident by
the absence of Purkinje neuron staining with a pan-Nova anti-
body at E18.5 (Figure S4A). Calbindin-positive Purkinje neurons
showed delayed migration in E18.5 Nova2 KO (Figure S4B), and
ectopic Purkinje neurons were evident in the cerebellar white
matter at P10 (p < 0.01; Figure 4A). These ectopic Purkinje cells
coexpressed other Purkinje markers, such as RORa and IP3R1,
but not markers for deep cerebellar nuclei neurons (Figures 4A
and S4C–S4E). Migrating Purkinje neurons were BrdU labeled
at E11.5, and the cerebellum was fixed at P4, revealing that
15% of BrdU/Calbindin double-positive cells were ectopically
located in the white matter of Nova2 KO cerebellum (Figures
4B and 4C). These data demonstrate that Nova2 is necessary
for correct cellular positioning of both cortical and Purkinje
neurons via radial migration.
Figure 3. Neural Progenitor Cells in WT and Nova2
KO Cortex
(A) BrdU was injected 1 hr before fixation. Coronal
sections of E14.5 cortex in WT and Nova2 KO brains
were immunostained with antibodies against Nestin (left
panel; green), which is a neural progenitor marker protein,
BrdU (right panel; red) and PH3 (right panel; green).
(B) This graph represents the number of BrdU-positive
cells per section.
(C) This graph represents the number of phospho-
Histone3 (PH3)–positive cells per sections. Error bar indi-
cates SD of three biological replicates. Scale bar, 50 mm.
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Splicing of Dab1 during Neural Development
Defects in cortical and Purkinje neuronal migration seen in Nova2
KO mice are similar to those seen with defects in reelin signaling
(D’Arcangelo et al., 1995; Ogawa et al., 1995; Larouche et al.,
2008). Moreover, we have previously found that Nova regulates
RNAs involved in synaptic molecules. Thus, we hypothesized
that, in the developing brain (E14.5), Nova2 might be a modifierFigure 4. Nova2 Regulates Purkinje Neuron Migration
(A) Calbindin staining (green) and counter staining with DAPI (blue) in P10 WT and Nova2 KO sagitta
fication orthogonal picture was enlarged from the boxed region in Nova2 KO cerebellum and doub
calbindin-positive neurons in cerebellum white matter in WT and Nova2 KO using three biological rep
Error bar represents SD using three biological replicates. CaBP, Calbindin. Scale bar, 100 mm.
(B and C) BrdU-labeling at E11.5 and immunostaining with BrdU (red) and calbindin (green) antibodies
at the level of vermis in cerebellum is shown in (B). High magnifications of Purkinje cell layers in WT
N2KO-1) and white matter in Nova2 KO (box region in B in N2KO-2) are shown in (C). Arrow indicates
the percentage of BrdU/calbindin double-positive cells in white matter per total double-positive cells
biological replicates. Asterisk indicates p < 0.05 by Student’s t test. Scale bar; 200 mm (B) and 20 mm (C
granule cell layer; N2KO, Nova2 KO.
Neuron 66of RNAs encoding reelin-signaling molecules,
leading to the neuronal migration defect we
observed in Nova2 KO mice. We did an unbi-
ased search for potential Nova action on such
RNAs, using HITS-CLIP, a method (Jensen
and Darnell, 2008; Ule et al., 2005a) that hasbeen used to map Nova-RNA direct interaction sites in vivo
(Licatalosi et al., 2008), and an exon junction array previously
shown to be able to identify RNA processing differences in
Nova KO and WT brain (Licatalosi et al., 2008; Ule et al.,
2005b). Nova2 HITS-CLIP in E14.5 cortex identified 27,576
robust cluster Nova2-binding sites in the mouse transcriptome
(Figure S5A), including several reelin pathway RNAs. When
exon junction arrays were probed with three biologic replicatesl sections at the level of vermis in cerebellum. High magni-
le stained with RORa (red). Quantitative results of ectopic
licates are shown (each 6 sections in cerebellar vermis).
at P4 cerebellum. Whole cerebellum in WT and Nova2 KO
(box region in B in WT) and Nova2 KO (box region in B in
BrdU/calbindin double-positive cells. Bar graph represents
in whole cerebellum. Error bar represents SD using three
). EGL, external granule layer; PCL, Purkinje cell layer; GL,
, 848–858, June 24, 2010 ª2010 Elsevier Inc. 851
Figure 5. Nova2 Regulates Alternative
Splicing of Dab1 in a Context-Dependent
Manner
(A) Scheme of Dab1 protein, which consists of PTB
domain and tyrosine phosphorylation sites, and
amino acids encoded by Dab1.7bc exons. PTB,
phospho-tyrosine binding.
(B) Nova2 CLIP tags from E14.5 cortex (blue/cyan/
purple) and P7 brains (red/orange/pink) by each
three individual color-coded CLIP experiments,
map to Nova2 regulating Dab1 transcripts. The
alternatively spliced region is highlighted. Two
red boxes in highlight indicate Dab1.7bc exons.
(C) Alternative splicing analysis of Dab1 in WT and
Nova2 KO using 5 time points: E10.5 brain, E14.5
cortex (Ctx), E16.5 Ctx, P0 Ctx, and P10 Ctx total
RNA. Each corresponding band was confirmed by
sequencing.
(D) Quantitation of Dab1 versus Dab1.7bc mRNA
expression data in (C); each point represents the
average of three biological replicates (see detailed
data in Figure S5C, which contain the ratio of
Dab1.7b/c and steady-state level of total Dab1
between embryo and postnatal cortex, as seen
in Figure S5B).
(E–G) Two upstream intronic sequences of
Dab1.7b and 7c exons are necessary for the regu-
lation of alternative splicing of Dab1.7bc exons as
a pair by Nova2. Schematic representation shows
pGloDab1.7bc and its derivative minigenes con-
taining the mouse intronic regions surrounding
exon 7b and 7c between human globin constitu-
tive exon1 and 3 (E). Asterisks indicate site of point
mutations in Nova binding YCAY clusters (see
Figures S5D and S5F for details). Total RNA was
isolated from 293T cells transiently transfected
with WT or mutant pGloDab1.7bc minigenes
(0.25 mg) and pNova2 (0.5 mg), as indicated, and
spliced products were analyzed by RT-PCR (F).
Three biological replicates were used in each anal-
ysis. Model of Nova2-mediated Dab1.7bc exon
repression is shown (G).
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Nova2 Regulates Dab1 and Neuronal Migrationof E14.5 WT or Nova2 KO cortical RNA, we identified no splicing
changes in 20 transcripts encoding reelin and other migration
signaling pathway proteins (Figure S5A and data not shown)
other than a very significant change (DI 0.8) (Licatalosi et al.,
2008; Ule et al., 2005b) in the Dab1 transcript. This change
was in a previously noted evolutionarily conserved pair of alter-
native exons with no defined function, termed Dab555 (Howell
et al., 1997a) or Dab1 exons 7b and 7c (Jelen et al., 2007; Ule
et al., 2006) (hereafter referred to as Dab1.7bc). We had previ-
ously noted that Dab1.7bc exons were among41 exons misre-
gulated in Nova1/Nova2 double KO mice (Ule et al., 2006).
The candidate reelin pathway RNAs identified as harboring
Nova-binding sites by HITS-CLIP were tested by RT-PCR. We
found no evidence for a specific early (E14.5) action of Nova2
to regulate any RNA other than Dab1. For example, alpha-cate-
nin2, which was previously identified as a Nova2 target RNA (Ule
et al., 2005b) and whose deficiency also leads to ectopic Purkinje
neurons (Park et al., 2002), was regulated by Nova2 at P10 but
had little Nova regulation evident at E14.5 (Figure S5A). Other852 Neuron 66, 848–858, June 24, 2010 ª2010 Elsevier Inc.transcripts had no significant Nova-dependent changes in
splicing or steady state mRNA levels at E14.5 (Figures S5A
and S5B), suggesting that these components of the reelin
signaling pathway were unlikely to underlie the neuronal migra-
tion defect evident in Nova2 null mice.
In contrast, Dab1 regulation correlated well with the observed
neuronal migration defect. The Dab1 transcript harbored a large
number of Nova2 CLIP tags in intronic sequences upstream of
the Dab1.7b/c exons (Figures 5A and 5B), in positions predicted
(Licatalosi et al., 2008; Ule et al., 2006) to inhibit exon inclusion.
To address the possibility of Nova2-dependent regulation of
Dab1 splicing during development, we performed RT-PCR
analysis of RNA obtained from the cortex of mice ranging in
age from E10.5 to P10. These data confirmed that the Dab1.7bc
exons were markedly overrepresented in E14.5–E16.5 Nova2
KO cortex relative to WT cortex, where they were barely utilized
(<20% of total) from E14.5–E16.5 onward; the Dab1.7bc exons
were down-regulated in Nova2 KO cortex postnatally (Figures
5C, 5D, and S5C). These results suggest that Nova2 normally
Neuron
Nova2 Regulates Dab1 and Neuronal Migrationsuppresses Dab1.7bc exon inclusion during the time of cortical
development and that other factors further suppress these
exons later in postnatal cortex.
To assess whether Nova2 might act directly on the Dab1 tran-
script to inhibitDab1.7bc exon inclusion, we generated a reporter
minigene expressing the Dab1.7bc genomic region. After trans-
fecting this reporter into 293T cells (which do not express Nova2)
together with increasing amounts of a Nova-expressing plasmid,
we measured Dab1.7bc alternative splicing by RT-PCR. These
experiments confirmed that Nova2 inhibits exon inclusion in
both 7b/c exons as a pair (Figures S5D–S5F). We then generated
minigenes in which three clusters of Nova-binding sites (YCAY
elements), identified by HITS-CLIP (Figure 5B) and bioinformatic
analysis, were independently mutated. Cotransfection assays
revealed that the Nova2-binding sites upstream of both 7b and
7c exons were necessary for Dab1.7bc exon exclusion by
Nova2; each binding site was independently necessary for
Nova inhibition of the immediate downstream exon (Dab1.7b
or c), and mutation of both sites abrogated Nova inhibition of
the Dab1.7bc exons as a pair (Figures 5E–5G). Interestingly,
these two regions were highly conserved element among
mammalian genome compared with the third Nova2-binding
site downstream of the Dab1.7bc exons, and mutation of this
third site had no effect on Nova-dependent splicing (mt3;
Figure 5F). Therefore, Nova2 acts directly on the Dab1 transcript
to inhibit inclusion of the paired 7b/c exons in a manner consis-
tent with the rules of the positional Nova-dependent splicing
map (Licatalosi and Darnell, 2010; Licatalosi et al., 2008; Ule
et al., 2006).
The aberrant Dab1.7bc exons encode a 33–amino acid
peptide of unknown function. We confirmed that a larger Dab1
protein isoform was the predominant isoform detectable by
Western blot of E14.5 mouse cortex in the absence of Nova2.
This band comigrated with Dab1.7bc expressed in transfected
tissue culture cells (Figures S6A and S6B) and was down-regu-
lated postnatally in WT or Nova2 KO cortex (data not shown).
Dab1 protein levels are known to be tightly controlled by phos-
phorylation following reelin-induction of tyrosine kinases and
subsequent protein degradation, and Dab1 levels are increased
in reelin-deficient mice (Hiesberger et al., 1999; Park and Curran,
2008; Rice and Curran, 2001). Consistent with these prior
studies, c-src overexpression induced equivalent levels of
Dab1 or Dab1.7bc phosphorylation and interaction with Crk;
however, in contrast to Dab1, the majority of Dab1.7bc is stable
by Western blot after c-src overexpression, perhaps by escaping
ubiquitination (Feng et al., 2007) (Figure S6C). Taken together,
our observations prompted us to explore whether aberrant
production of the Dab1.7bc isoform could account for the
Nova2 cortical migration phenotype.
The Balance between Dab1 and Dab1.7bc Isoforms
Regulates Neuronal Migration
To test whether Dab1.7bc was sufficient to induce the neuronal
migration defect evident in Nova2 KO mice, we performed in
utero electroporation experiments, an extension of an approach
originally used to study the effects of neuronal Elavl proteins on
neuronal development (Akamatsu et al., 1999). In these studies,
we introduced plasmid DNA encoding WT Dab1 or the Dab1.7bcisoform into lateral ventricle in the developing neocortex of WT or
Nova2 KO mice at E14.5. Control pcDNA3 vector or Dab1
expressing plasmids were electroporated together with a
plasmid encoding mRFP to allow tracing of electroporated cells
in vivo. Following electroporation, pregnant mothers were
allowed to continue gestation; four days later, pups were sacri-
ficed and the effects of plasmid transfection were assessed by
monitoring mRFP labeled cells. In WT mice, 80% of mRFP-
labeled cells were clearly located at upper cortical plates
4 days after electroporation. Remarkably, transfection of plas-
mid encoding Dab1.7bc in WT mice caused cortical plate
neurons to migrate to aberrant positions (Figures 6A and 6B),
recapitulating the migration defect seen in Nova2 KO mice
(Figures 1 and 2). Although we cannot determine the degree of
Dab1.7bc overexpression in the small number of neurons trans-
fected in these experiments, we anticipate that they are high
relative to the very small amount of residual Dab1, given the
robust expression of Dab1.7bc from this construct in tissue
culture cells (Figure S6A), and evidence that this promoter
expresses well in early postmitotic cortical neurons (Hagino-
Yamagishi et al., 1997). These results indicate that the Dab1.7bc
isoform itself is able to induce a neuronal migration defect.
In addition to the de novo production of Dab1.7bc, Nova2 KO
mice are deficient in production of the WT Dab1 signaling mole-
cule; Dab1 levels are decreased to 35% WT levels in E14.5
Nova2 KO cortex (Figures S6A and S6B). Therefore, we next ad-
dressed whether reintroduction of the WT Dab1 isoform can miti-
gate the migration defect in Nova2 KO neocortex. When control
plasmid together with mRFP was introduced into Nova2 KO
neocortex, mRFP-positive cells were separated in upper cortical
plate and aberrant cortical positions (Figures 6C and 6D), reflect-
ing the neuronal migration defect. In the rescue experiment, in
which plasmid expressing the WT Dab1 isoform was electropo-
rated into Nova2 KO cells, we found that the migration of the
mRFP-positive cells population was significantly shifted toward
its normal position in the upper cortical plate. Importantly, both
the mispositioned and normal positioned mRFP-positive cells
in Nova2 KO are Cux1 positive, which marks Layer II–IV neurons
(Figures 6C and 6D). These results demonstrate that the
neuronal splicing factor Nova2 regulates neuronal migration
during embryonic brain development through reelin-Dab1 sig-
naling pathway, and that maintenance of an appropriate balance
between Dab1 and Dab1.7bc isoforms may be required for
normal migration.
We next assessed whether Dab1.7bc is able to dysregulate
neuronal migration in the setting of reduced Dab1 levels. We per-
formed Dab1 knockdown (KD) with Dab1-specific shRNAs intro-
duced by in utero electroporation. As expected, this led to
a neuronal migration defect in WT mice (a 43% reduction in the
number of neurons successfully migrating to the upper cortical
plate compared with control; Figures 6E and 6F). Again, we
were unable to measure the degree of Dab1 knockdown in the
small number of neurons transfected in vivo, but this shRNA
construct led to 80%–90% reduction of Dab1 expression in
tissue culture cells (Figure S6D); the small residual Dab1 expres-
sion may explain the failure to completely block migration in this
experiment. Importantly, this phenotype by Dab1 KD could be
rescued by coelectroporation of the wild-type Dab1 expressionNeuron 66, 848–858, June 24, 2010 ª2010 Elsevier Inc. 853
Figure 6. WT Dab1 Mitigates, and Dab1.7bc
Exacerbates, Neuronal Migration Defects
Expression plasmids of mRFP together with
control or Dab1 or Dab1.7bc were injected into
lateral ventricle of E14.5 embryo brain and electro-
porated into the region of neocortex, and trans-
fected cells were imaged in the RFP channel.
(A and C) WT (A) and Nova2 KO (C) brains were
fixed at 4 days later and examined. High magnifi-
cations were double stained with Cux1 and mRFP.
(B and D) Graphs quantify mRFP-positive cells in
each of four regions (marginal zone [MZ], and
upper, middle and lower cortical plates [CP], as
illustrated in A and C) as a percentage of total
mRFP-positive cells. Scale bar, 100 mm and
20 mm (high magnifications). Data represent the
mean ± SD of three WT or Nova2 KO brains.
Results were compared to WT (B) or Nova2 KO
(D) control vector and showed no significant differ-
ence in WT brain transfected with Dab1 (p = 0.2),
but significant differences with WT brain trans-
fected with Dab1.7bc (p < 0.001) or Nova2 KO
brain transfected with Dab1 (p < 0.01) by
repeated-measures ANOVA.
(E and F) Control and Dab1 shRNA expression
vectors were injected together with Dab1 or
Dab1.7bc expression vectors and mRFP into the
lateral ventricle of E14.5 embryo brain, electropo-
rated, and analyzed 4 days later. (E) indicates
representative results, and (F) shows the ratio of
the mRFP-positive cells in upper cortical layer
per total mRFP-positive cells in cortical plate as
indicated in (E). Error bar represents SD using
three biological replicates. Asterisks indicate
p < 0.01 by Student’s t test.
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Nova2 Regulates Dab1 and Neuronal Migrationconstruct (Figures 6E, 6F, and S6E). Remarkably, cotransfection
of the Dab1.7bc expression construct not only failed to rescue
the migration defect in Dab1 KD neurons, but exacerbated the
migration defect (Figures 6E, 6F, and S6E). These results
suggest that Dab1.7bc itself may have a toxic or dominant nega-
tive action to antagonize wild-type Dab1 action in mediating neu-
ronal migration.
DISCUSSION
In the present work, we link Nova2 function to a switch in
alternative splicing of Dab1 isoforms and in neuronal migration.
Genomewide mapping of Nova:RNA interactions in the brain
with HITS-CLIP and exon junction arrays was previously used
to identify and predict functional interaction sites (Licatalosi
et al., 2008; Ule et al., 2005a; Racca et al., 2010). The present
study extends these findings to identify a new role for Nova2 in
the developing brain by combining histologic analysis of cortical
development with a directed analysis of HITS-CLIP and exon
array data to examine regulation of the reelin pathway. Biologic
experiments in Nova2 null mice demonstrate that Nova2 is
a novel reelin signal modifier and regulates radial migration of
cortical neuron and Purkinje neurons. To our knowledge, this
study provides the first in vivo evidence that alternative splicing
regulation controls neuronal migration, as well as providing
a mechanism for how it does so.854 Neuron 66, 848–858, June 24, 2010 ª2010 Elsevier Inc.Histological analysis showed that Nova2 deficiency results in
ectopic cortical neurons and Purkinje neurons (Figures 1 and 4).
In the neocortex, Cux1-positive (Layer II–IV) and Brn-2-positive
(Layer II/III and Va) late-generated neurons are more severely
mislocalized in Nova2 null mice in deep layers than are early-
generated neurons (Er81-positive [LayerV] and FoxP2-positive
[Layer VI] cells; Figures 1 and S1). These late-generated neurons
generally use radial glia processes as a scaffold to move long
distances from the proliferative zone to the superficial cortical
layer when the layer of cortex formed in an inside-out manner,
whereas early-generated neurons mainly use somal transloca-
tion mode that is unnecessary in a radial fiber early in develop-
ment when the radial glial scaffolds have not formed yet (Rakic,
2003; Rakic and Caviness, 1995; Nadarajah et al., 2001; Nadar-
ajah and Parnavelas, 2002). Importantly, the radial glia forms
normally in Nova2 KO; histone H3 staining and short term
BrdU labeling showed that the proliferation and mitotic polarity
of radial glia, which give rise to newborn neurons, were normal
in Nova2 null mice (Figure 3). This finding suggests that the
mislocation of neurons in Nova2 null mice is due to a defect of
neuronal migration after their terminal cell division, a conclusion
supported by the BrdU birth-date studies and electroporation
analysis of mRFP-positive cells in Nova2 KO animals demon-
strating neuronal migration defects (Figures 2, 4, and 6).
We pursued the mechanism underlying the neuronal migration
defect in Nova2 KO mice after recognizing its similarity with
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Nova2 Regulates Dab1 and Neuronal Migrationpreviously reported migration defects. Many previous genetic
approaches have shown that reelin-Dab1 signaling shows
neuronal migration defects in both cortical and Purkinje neurons,
as noted in Nova2 null mice. In fact, mislocation of cortical and
Purkinje neurons in Nova2 KO is very similar to defects seen in
Apoer2 KO mice, which is one of two reelin receptors. Apoer2
KO mice displayed migration defects of late-generated cortical
neurons and ectopic Purkinje cells. Interestingly, loss of function
of another reelin receptor, Vldlr, leads to a different phenotype,
showing milder phenotypes for cortical migration and more
severe Purkinje neurons migration than Apoer2 KO (Hack et al.,
2007; Larouche et al., 2008). ApoER2/Vldlr double mutants, or
mutations in their adaptor molecule, Dab1, show defects as
severe as reeler phenotypes (Trommsdorff et al., 1999). In this
study, we could not find any differences in the steady-state RNA
levels, alternative splicing, or proteins level of reelin or its recep-
tors in Nova2 KO embryo and postnatal brain (Figures 5 and S5).
We focused on alternative splicing changes ofDab1 exon7b/c,
previously reported as one of many Nova targets encoding
synapse-related proteins (Ule et al., 2006). Interestingly,
a previous study had shown that the Dab1.7bc/Dab1 ratio is
decreased during differentiations of P19 cells induced by retinoic
acid (Bar et al., 2003). Moreover, in chicks, where only the
Dab1.7c exon is present prior to a likely genome duplication
event in mammals (Figure 5; Ule and Darnell, 2007; Jelen et al.,
2007), Dab1.7c was found to be regulated during chick retina
development and was again correlated with postmitotic differen-
tiation (Katyal and Godbout, 2004). These studies are consistent
with the results found here for a role for Nova2 in regulating
Dab1.7bc expression and postmitotic neuronal migration.
HITS-CLIP, exon array/RT-PCR, and in vitro minigene analysis
studies demonstrate that Nova2 directly binds predicted YCAY
clusters to block inclusion of the Dab1.7bc exons (Figure 5).
Although it was previously suggested that Dab1.7bc was
expressed and therefore might act earlier in development (Bar
et al., 2003), we find that its action is restricted to migrating
neurons versus proliferative neural progenitors because of the
restricted expression of Nova2 (Figure S1). In summary, our
data demonstrate not only a function for Dab1.7bc, but the
mechanism by which it is regulated, which is by direct Nova2
action on upstream YCAY clusters to block exon inclusion in
a manner consistent with the predicted position-dependent
map of Nova functional exon regulation (Figure 5; Licatalosi
et al., 2008; Ule et al., 2006). Recently, a machine-learning
strategy developed to predict the action of Nova and other
RBPs confirmed the Nova-dependent positional map in adult
brain, but suggested that this pattern might be reversed for
a substantial number of exons in the embryo (Barash et al.,
2010). Although we did not find evidence to support this predic-
tion in the current work, the issue warrants further study.
Overexpression of Dab1.7bc induced neuronal migration
defects in WT animals and exacerbated this defect in Dab1 KD
brain after in utero electroporation analysis; conversely, WT
Dab1 can rescue the neuronal migration defect in Nova2 KO
mice (Figure 6). Interestingly, this alternative splicing change is
regulated in a context- and age-dependent manner. Nova-
dependent alternative splicing suppression of Dab1.7bc is high-
est in the E14.5–E16.5 cortex, the critical time window inneuronal migration for late-born neurons in neocortex, and is
gradually diminished up to P10 (Figure 5). Presumably,Dab1.7bc
has a transient but, given its evolutionary conservation, impor-
tant role early in development that is regulated both by Nova2
during neuronal migration and by other RBPs in the postnatal
brain. Recent studies revealed that Reelin signaling is involved
not only in early development, including neuronal migration,
but also in dendrite biogenesis and synapse formation in the
postnatal brain (Niu et al., 2008), and it seems reasonable to
assume that Dab1.7bc and/or alternative switching between
the two Dab1 isoforms also has a physiological role in the
adult brain.
Previous studies have shown that Dab1 is necessary for two
critical and quite different events in radial migration: (1) to
migrate past early generated neurons and (2) to allow detach-
ment from radial glia to cause migrating neurons to stay at
a correct layer position (Sanada et al., 2004). Detailed single-
mutant analysis of the two reelin receptors revealed that ApoER2
signaling plays an important role in proper migration of late-
generated neurons, whereas Vldlr signaling mediates a ‘‘stop
signal’’ to prevent migrating neurons into marginal zones (Hack
et al., 2007). Additionally, these two receptors show completely
different cellular localization by a fractionation analysis of lipid
rafts—ApoER2, but not Vldlr, is mainly localized to lipid rafts,
which are caveolin1-enriched fractions (Mayer et al., 2006).
Nova2 KO phenotypes are very similar to those of Apoer2 KO,
but not Vldlr KO, mice, showing two visible late-generated
neuronal bands but not invasion of migrated neurons into the
marginal zone (Figures 1 and 2). Our data are therefore consis-
tent with the Dab1/Dab1.7bc balance acting downstream of
ApoER2, but not Vldlr, perhaps through localization of receptor
trafficking and protein degradation (Hack et al., 2007; Larouche
et al., 2008; Mayer et al., 2006).
Dab1 can orchestrate many downstream signaling pathways,
including PI3K-Akt, crk, LIS1, integrin, and notch signaling (Ayala
et al., 2007; Hashimoto-Torii et al., 2008). We do not know
whether the Dab1.7bc protein domain might affect the ability
of the Dab1 PTB domain to interact with Crk, but the Dab1.7bc
does appear to escape the degradation pathway after src induc-
tion (Figure S6). Improved reagents will be required to undertake
more detailed localization and biochemical analysis of Dab1
isoforms.
Our observations suggest that Nova-dependent regulation
of Dab1/Dab1.7bc splicing is able to switch neurons from a
reelin-responsive to a reelin-unresponsive state, thereby medi-
ating inside-out cortical lamination. Our results add Nova2-
dependent control of neuronal migration to the list of factors
that contribute to the complexity of cortical development and
suggest that alternative splicing switches may provide a general
means of regulating key developmental events in mammalian
biology and developmental neurologic disorders.EXPERIMENTAL PROCEDURES
Histology and BrdU analysis
Postnatal mice were perfused transcardially with 4% paraformaldehyde phos-
phate-buffered saline, and brains were removed and postfixed in same fixative
followed by cryo-protection with 30% sucrose/PBS for cryostat (16 mm)Neuron 66, 848–858, June 24, 2010 ª2010 Elsevier Inc. 855
Table 1. Summary of Nova2 HITS-CLIP
Sample Total Read Annotated to Genome Unique Tags
E14.5Ctx1-N2 8,782,833 1,758,473 71,152
E14.5Ctx2-N2 9,581,435 2,497,832 60,406
E14.5Ctx3-N2 9,112,841 1,840,583 37,589
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Nova2 Regulates Dab1 and Neuronal Migration(CM3050S, LEICA) or were sliced with a vibratome (50 mm) (VT1000S, LEICA).
For 5-bromodeoxyuridine (BrdU) analysis, the pregnant mothers were injected
with BrdU (Sigma-Aldrich) dissolved in 0.9% NaCl (50 mg/kg, i.p.) at indicated
periods. The embryos or P0 pups were then processed for immunohistochem-
istry (IHC). Sections were incubated in 2 N HCl for 30 min at room temperature
for anti-BrdU staining or were boiled in 10 mM citric acid buffer (pH 6.0) for
5min three times for Nova2, PH3, Calbindin, IP3R1, GFP, NeuN, and RORa
before IHC. Sections were incubated overnight at 4C with primary antibodies
(see Supplemental Information) followed by incubation with Alexa-dye
conjugated secondary antibodies (Invitrogen 1:1000) or by the combination
of biotinylated secondary antibodies (Jackson laboratory 1:500), the VECTAS-
TAIN Elite ABC kit (Vector Laboratories), and visualization by using the TSA
Fluorescence system (PerkinElmer Life). The images of immunostained
specimens were collected by either a universal fluorescence microscope
(Axiophot 2) or a confocal laser scan microscope (LSM510) (Carl Zeiss) at
the Bio-Imaging Resource Center at The Rockefeller University.
Western Blot, RT-PCR, and qRT-PCR
Western blotting and RT-PCR analyses were performed as described else-
where (Dredge and Darnell, 2003). Quantitative PCR was used at least three
biological replicates with a MyiQ single-color real-time PCR detection system,
using mouse b-actin or GAPDH as an internal control, and calculated with DD
Ct methods.
Exon Junction Microarray
Nova-dependent alternative splicing was assessed using exon junction arrays
as described elsewhere (Licatalosi et al., 2008).
HITS-CLIP
CLIP was performed on E14.5 WT mouse cortex using three biological repli-
cates, as described elsewhere (Licatalosi et al., 2008), and anti–goat IgG
was used as a negative control. In PCR amplification, high-throughput
sequencing was performed using Solexa-primers at The Rockefeller University
Genome Resource Center. Sequence tags were aligned to the mouse genome
(mm9) by BOWTIE. Unique tags were collected by eliminating duplicates of
those tags that had the same sequence start on the same strand (Table 1).
In Utero Electroporation
DNA solution (1 ml) in PBS containing 0.01% fast green was injected into the
lateral ventricle of E14.5 embryos, as described elsewhere (Tabata and Naka-
jima, 2001). After injection, electronic pulses of 30 V were charged six times at
950 ms intervals using a square-pulse electroporator (CUY21EDIT; Protech).
The plasmid mRFP-pcXN2 (0.5 mg/ml), an expression vector under the control
of the CAG promoter, was electroporated together with pcDNA3-Dab1 or
Dab1.7bc (1.0 mg/ml). Four days after electroporation, the embryos were
then processed for IHC (see above).
Minigene Analysis
A Dab1.7bc chimeric minigene (termed pGloDab1.7bc) was derived from the
pGLO g (Dredge and Darnell, 2003) by the insertion of 822 bp of mouse
genomic sequence around Dab1.7b and 7c exons by PCR amplification.
All mutant pGloDab1.7bc constructs were generated by site-direct PCR
(detailed mutant sequences are described in Figures S5D and S5F). All frag-
ments generated by PCR were confirmed by complete DNA sequencing.
293T cells were transfected with 0.25 mg of the appropriated reporter mini-
genes together with 0.5 mg of pNova2 (Licatalosi et al., 2008) or EGFP control
vector, using FuGENE HD (Roche) as described by the manufacturer. After 40
hr, cells were rinsed with ice-cold PBS and collected by TRIZOL for RNA856 Neuron 66, 848–858, June 24, 2010 ª2010 Elsevier Inc.extraction. RT-PCR was performed using PCR primers to human b-globin
E1F and E3R, as described elsewhere (Dredge and Darnell, 2003).
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes details on DNA constructs,
antibodies, mice, primers for QRT-PCR and RT-PCR, coimmunoprecipitation,
and western blotting, and six figures and can be found with this article online at
doi:10.1016/j.neuron.2010.05.007.
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